https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-6139
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-61392021-02-26 00:00:002021-02-26 00:00:00ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-1996
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-19962021-01-28 00:00:002021-01-28 00:00:00Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-12-28 / Pharmacol Res 2021 Feb;164:105374
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-12-28 / Pharmacol Res 2021 Feb;164:1053742020-12-28 00:00:002020-12-28 00:00:00Dendritic cell vaccine therapy for colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-12-24 / Cancers (Basel) 2020 Dec;13(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-12-24 / Cancers (Basel) 2020 Dec;13(1)2020-12-24 00:00:002021-11-15 13:17:14Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)2020-11-17 00:00:002024-08-26 09:18:25A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-27 / Front Oncol 2020;10:605633
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-27 / Front Oncol 2020;10:6056332020-10-27 00:00:002020-10-27 00:00:00Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-26 / Front Oncol 2020;10:536700
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-26 / Front Oncol 2020;10:5367002020-10-26 00:00:002020-10-26 00:00:00High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-14 / Nat Commun 2020 10;11(1):5173
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-14 / Nat Commun 2020 10;11(1):51732020-10-14 00:00:002020-10-14 00:00:00Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-10-01 / Anticancer Res 2020 Oct;40(10):5765-5776
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-10-01 / Anticancer Res 2020 Oct;40(10):5765-57762020-10-01 00:00:002020-10-01 00:00:00Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-08-31 / J Clin Oncol 38: 2020 (suppl; abstr 3000)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-08-31 / J Clin Oncol 38: 2020 (suppl; abstr 3000)2020-08-31 08:24:242020-08-31 08:24:24Pilot study on outcome and antitumor efficacy of an autologous cancer cell vaccine applied in patients with advanced solid tumors.
